Welcome to PsychU!

Depression

Major depressive disorder affects millions of Americans, causing high costs in both human suffering and medical expenditures. Here in this library you will find hundreds of helpful resources to help in diagnosis and treatment.

Featured Resources

New Intensive Transcranial Magnetic Stimulation Is Nearly 80% Effective In Treating Depression

New Intensive Transcranial Magnetic Stimulation Is Nearly 80% Effective In Treating Depression

A new, intensive, individualized type of transcranial magnetic stimulation (TMS) is nearly 80% effective in treating depression. After five days of treatment, 78.6% of the participants in the treatment group were no longer depressed. This type of TMS is called Stanford neuromodulation therapy (SNT). It delivers individualized intermittent theta-burst stimulation…
New Intensive Transcranial Magnetic Stimulation Is Nearly 80% Effective In Treating Depression

New Intensive Transcranial Magnetic Stimulation Is Nearly 80% Effective In Treating Depression

A new, intensive, individualized type of transcranial magnetic stimulation (TMS) is nearly 80% effective in treating depression. After five days of treatment, 78.6% of the participants in the treatment group were no longer depressed. This type of TMS is called Stanford neuromodulation therapy (SNT). It delivers individualized intermittent theta-burst stimulation…

Upcoming Events

Section Advisors

  • Charles Raison, MD

    Major Depressive Disorder Section Advisor

  • Gaurava Agarwal, MD

    Major Depressive Disorder Section Advisor

Ask A Question About Depression

Enter your question in the box below and click “Ask My Question” to submit your inquiry.

You must be logged in to ask a question in this section.

Disclaimer: The information provided by PsychU is intended for your educational benefit only. It is not intended as, nor is it a substitute for medical care or advice or professional diagnosis. Treatment-related questions will not be addressed. Users seeking medical advice should consult with their physician or other healthcare professional.

Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) operates in a highly regulated and scrutinized industry. Therefore, we may not be able to address every questions or topic submitted. Topics which may not be addressed may include, but are not limited to questions related to: (1) specific medications, (2) branded items, (3) clinical or treatment advice relating to specific patient conditions. The lack of response to certain questions or comments should not be taken as an agreement with the view posed or an admission of any kind.

REQUEST A PRESENTATION

Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.

Top Requested Presentations

The Neuropsychiatric Inventory: Development & Applications

Diagnostic & Statistical Manual Of Mental Disorders–Fifth Edition (DSM-5): Key Updates VS DSM-IV-TR

Distinguishing Sedation From Efficacy In Antipsychotic Treatment

Learning Tracks